Avalon Global Asset Management Upped Athenahealth (ATHN) Holding; Iradimed (IRMD) SI Increased By 1.02%

February 22, 2018 - By Dolores Ford

Iradimed Corporation (NASDAQ:IRMD) had an increase of 1.02% in short interest. IRMD’s SI was 902,400 shares in February as released by FINRA. Its up 1.02% from 893,300 shares previously. With 28,600 avg volume, 32 days are for Iradimed Corporation (NASDAQ:IRMD)’s short sellers to cover IRMD’s short positions. The SI to Iradimed Corporation’s float is 20.29%. The stock increased 2.25% or $0.3 during the last trading session, reaching $13.65. About 4,796 shares traded. IRadimed Corporation (NASDAQ:IRMD) has declined 54.40% since February 22, 2017 and is downtrending. It has underperformed by 71.10% the S&P500.

Avalon Global Asset Management Llc increased Athenahealth Inc (ATHN) stake by 14.45% reported in 2017Q3 SEC filing. Avalon Global Asset Management Llc acquired 5,780 shares as Athenahealth Inc (ATHN)’s stock rose 9.63%. The Avalon Global Asset Management Llc holds 45,780 shares with $5.69M value, up from 40,000 last quarter. Athenahealth Inc now has $5.58 billion valuation. The stock increased 1.61% or $2.21 during the last trading session, reaching $139.08. About 143,045 shares traded. athenahealth, Inc. (NASDAQ:ATHN) has risen 0.90% since February 22, 2017 and is uptrending. It has underperformed by 15.80% the S&P500.

Investors sentiment decreased to 0.42 in 2017 Q3. Its down 0.14, from 0.56 in 2017Q2. It turned negative, as 8 investors sold IRadimed Corporation shares while 11 reduced holdings. 5 funds opened positions while 3 raised stakes. 1.46 million shares or 1.81% less from 1.49 million shares in 2017Q2 were reported. Blackrock Inc reported 42,540 shares stake. Bnp Paribas Arbitrage Sa invested 0% in IRadimed Corporation (NASDAQ:IRMD). Dimensional Fund Limited Partnership stated it has 10,885 shares. Commercial Bank Of Ny Mellon Corporation holds 0% of its portfolio in IRadimed Corporation (NASDAQ:IRMD) for 15,432 shares. Northern Tru holds 0% or 20,897 shares. Spark Ltd Liability Corp stated it has 0.02% of its portfolio in IRadimed Corporation (NASDAQ:IRMD). Deutsche Bancorp Ag has invested 0% in IRadimed Corporation (NASDAQ:IRMD). Neuberger Berman Limited Liability owns 0% invested in IRadimed Corporation (NASDAQ:IRMD) for 20,500 shares. Royal National Bank Of Canada owns 0% invested in IRadimed Corporation (NASDAQ:IRMD) for 1,628 shares. Tower Research Limited Liability Company (Trc) invested in 0% or 1,232 shares. Ameriprise Fincl stated it has 456,810 shares or 0% of all its holdings. Geode Capital Management Llc holds 25,310 shares. Morgan Stanley holds 0% in IRadimed Corporation (NASDAQ:IRMD) or 39,976 shares. Vanguard Group Incorporated Inc reported 0% in IRadimed Corporation (NASDAQ:IRMD). Citigroup Incorporated owns 3,631 shares.

Iradimed Corporation develops, manufactures, markets, and distributes magnetic resonance imaging compatible products, and related accessories and services in the United States and internationally. The company has market cap of $144.08 million. It offers MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets under the MRidium name; and MRI compatible patient vital signs monitoring system under the IRadimed name. It has a 341.25 P/E ratio. The firm also offers IV poles, wireless remote displays/controls, side car pump modules, dose error reduction systems, and SpO2 monitoring with sensors and accessories; iMagox MRI pulse oximeter; and iMagox MRI oximeter remote and display products.

Among 3 analysts covering iRadimed (NASDAQ:IRMD), 3 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. iRadimed had 9 analyst reports since July 30, 2015 according to SRatingsIntel. Roth Capital maintained IRadimed Corporation (NASDAQ:IRMD) on Tuesday, October 31 with “Buy” rating. On Wednesday, October 5 the stock rating was downgraded by Roth Capital to “Neutral”. The rating was maintained by Roth Capital with “Buy” on Monday, November 2. The stock has “Buy” rating by Roth Capital on Monday, April 4. The stock of IRadimed Corporation (NASDAQ:IRMD) has “Buy” rating given on Monday, November 27 by Credit Suisse. The firm earned “Buy” rating on Monday, November 2 by TH Capital. As per Monday, July 31, the company rating was upgraded by Roth Capital. The firm earned “Buy” rating on Thursday, July 30 by TH Capital. Roth Capital maintained IRadimed Corporation (NASDAQ:IRMD) on Tuesday, January 23 with “Buy” rating.

Since September 1, 2017, it had 0 buys, and 14 selling transactions for $7.43 million activity. $19,239 worth of athenahealth, Inc. (NASDAQ:ATHN) shares were sold by Porter Jonathan D.. 5,000 athenahealth, Inc. (NASDAQ:ATHN) shares with value of $669,698 were sold by ROBINSON DAVID ERIC. Another trade for 5,000 shares valued at $669,515 was sold by Bush Jonathan. Hull Brandon H had sold 800 shares worth $112,760. Haley Daniel P sold $197,180 worth of athenahealth, Inc. (NASDAQ:ATHN) on Sunday, October 1. Another trade for 1,000 shares valued at $128,555 was made by Armbrester Bradford Kyle on Friday, October 27.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.